May 10, 2016 — MEDraysintell announced it will display its series of market reports and directories during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) congress, June 11-15, in San Diego. The reports contain over 1,800 pages of intelligence covering nuclear medicine, cyclotrons, brachytherapy and proton therapy.

MIM Software Inc. announced that GenesisCare Australia has selected MIM Maestro as their radiotherapy contouring and deformable registration solutions platform across the Genesis Cancer Care Network in Australia.

Varian Medical Systems Inc. announced the release of new computer-aided engineering (CAE) software for simplifying the process of designing shielding and radiological protection systems.

XmaruView mini-Archive Viewer

Rayence announced the availability of the new XmaruView Image Acquisition Software, Version 4.0, with a host of new features.

Cardiovascular magnetic resonance (CMR) is a stronger predictor of risk for major adverse cardiovascular events (MACE) than single-photon emission computed tomography (SPECT) at five years follow-up.

Longer time spent by film readers interpreting screening mammograms did not result in a reduced rate of breast cancer detection, according to a study appearing in the May 10 issue of JAMA.

Gamma Medica, provider of molecular breast imaging technology (MBI), announced it has launched the Be Certain campaign, featuring a dedicated microsite as the cornerstone of an initiative to spread awareness on breast density.

A recent study demonstrates that Ga-68 DOTATATE positron emission tomography (PET)/computed tomography (CT) scans are superior to In-111 pentetreotide scans, the current imaging standard in the United States for detecting neuroendocrine tumors (NETS).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now